- Home
- NVCR vs SXI Comparison
NVCR vs SXI Comparison
Compare NVCR & SXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCR
- SXI
- Stock Information
- Founded
- NVCR 2000
- SXI 1955
- Country
- NVCR Switzerland
- SXI United States
- Employees
- NVCR N/A
- SXI N/A
- Industry
- NVCR Medical/Dental Instruments
- SXI Industrial Machinery/Components
- Sector
- NVCR Health Care
- SXI Industrials
- Exchange
- NVCR Nasdaq
- SXI Nasdaq
- Market Cap
- NVCR 1.9B
- SXI 2.3B
- IPO Year
- NVCR 2015
- SXI N/A
- Fundamental
- Price
- NVCR $17.60
- SXI $163.12
- Analyst Decision
- NVCR Buy
- SXI Strong Buy
- Analyst Count
- NVCR 7
- SXI 3
- Target Price
- NVCR $32.43
- SXI $223.33
- AVG Volume (30 Days)
- NVCR 1.3M
- SXI 142.9K
- Earning Date
- NVCR 07-24-2025
- SXI 07-31-2025
- Dividend Yield
- NVCR N/A
- SXI 0.77%
- EPS Growth
- NVCR N/A
- SXI N/A
- EPS
- NVCR N/A
- SXI 5.04
- Revenue
- NVCR $621,711,000.00
- SXI $748,252,000.00
- Revenue This Year
- NVCR $5.56
- SXI $9.67
- Revenue Next Year
- NVCR $9.19
- SXI $12.91
- P/E Ratio
- NVCR N/A
- SXI $32.34
- Revenue Growth
- NVCR 18.27
- SXI 2.67
- 52 Week Low
- NVCR $14.17
- SXI $128.85
- 52 Week High
- NVCR $34.13
- SXI $212.66
- Technical
- Relative Strength Index (RSI)
- NVCR 49.74
- SXI 55.30
- Support Level
- NVCR $16.81
- SXI $163.30
- Resistance Level
- NVCR $18.59
- SXI $169.98
- Average True Range (ATR)
- NVCR 0.74
- SXI 4.51
- MACD
- NVCR 0.08
- SXI 0.39
- Stochastic Oscillator
- NVCR 56.18
- SXI 56.05
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About SXI Standex International Corporation
Standex International Corp is an industrial manufacturer of different products and services used in commercial and industrial markets. It has five reportable segments; Electronics; Engraving; Scientific; Engineering Technologies and Specialty Solutions. The maximum revenue is generated from its Electronics segment which is a component and value-added services provider of both sensing and switching technologies as well as magnetic power conversion components and assemblies, like custom wound transformers and inductors, current sense technology, value-added assemblies, and mechanical packaging among others. Geographically, it derives key revenue from the United States and the rest from Asia Pacific, Europe, Middle East and South Africa (EMEA), and other regions.